无症状三尖瓣反流的定量超声心动图评估及早期干预的最佳标准
研究基于2004至2018年Cleveland Clinic超声心动图数据库,连续纳入325例无症状中重度(3+)或重度(4+)三尖瓣反流患者,回顾性定量评估三尖瓣反流及右心参数对全因死亡的预后价值。右心室游离壁应变(RVFWS)和三尖瓣反流容积(RVol)是最强预测因子,最佳阈值分别为RVFWS<-19%和RVol>45 mL;无危险因素、1个危险因素和2个危险因素患者的5年生存率分别为93%、65%和38%。
要点
- 无症状3+及以上三尖瓣反流患者中,RVFWS<-19%和RVol>45 mL是死亡的最强预测指标。
- 按危险因素数目分层,无、1个和2个危险因素患者的5年生存率分别为93%、65%和38%。
- 无症状且无或仅1个危险因素者死亡率低于有症状三尖瓣反流患者,但2个危险因素者死亡率与之相似。
核心结论
- RVFWS和RVol是可连续监测的关键预后标志物,有助于指导重度无症状三尖瓣反流的最佳干预时机。
研究设计与样本
- 回顾性队列研究,利用Cleveland Clinic 2004至2018年超声心动图数据库,连续纳入325例无症状中重度(3+)或重度(4+)三尖瓣反流患者,定量测定三尖瓣反流及右心参数,评估全因死亡的预后价值;并与年龄、性别匹配的有症状三尖瓣反流队列比较。
关键影像表现/征象
- 无症状三尖瓣反流患者中,RVFWS和RVol是所有评估的超声心动图参数中死亡的最强预测因子。
- RVFWS<-19%和RVol>45 mL为最佳判别阈值。
诊断标准与关键数值
- RVFWS<-19%和RVol>45 mL为无症状三尖瓣反流患者死亡风险的最佳判别阈值。
- 无危险因素、1个危险因素和2个危险因素患者的5年生存率分别为93%(95% CI:86%-96%)、65%(95% CI:55%-74%)和38%(95% CI:26%-49%)。
- 与有症状三尖瓣反流相比,无症状且无危险因素者死亡风险HR为0.10(95% CI:0.04-0.29),1个危险因素者HR为0.29(95% CI:0.14-0.58),2个危险因素者HR为1.11(95% CI:0.56-2.19)。
临床应用与阅片要点
- 对无症状3+及以上三尖瓣反流患者,可定量测量RVFWS和RVol以进行风险分层。
- RVFWS<-19%和RVol>45 mL可作为识别高危无症状患者的超声指标。
- 无危险因素或仅1个危险因素的无症状患者死亡风险低于有症状患者,而2个危险因素者死亡风险与有症状患者相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Significant tricuspid regurgitation (TR) is associated with poor outcome and high operative mortality resulting from late presentation. Yet, the optimal timing for intervention is unknown.
OBJECTIVES: The purpose of this study was to evaluate the prognostic value of echocardiographic parameters to inform early intervention in asymptomatic TR.
METHODS: Using the Cleveland Clinic echocardiography database 2004 to 2018, the authors identified a consecutive cohort of asymptomatic patients with moderate to severe (3+) or severe (4+) TR. Quantitative TR and right heart parameters were retrospectively determined, and their prognostic utility for all-cause mortality was assessed.
RESULTS: In 325 asymptomatic patients (mean age: 67.9 years; 79.4% female) with at least 3+ TR, there were 132 deaths (40.6%), with a median survival time of 9.9 years (95% CI: 7.9-12.7 years). By contrast, the median survival time in an age- and sex-matched cohort of symptomatic TR patients was 4.4 years (95% CI: 2.8-5.9 years). Among all the echocardiographic parameters evaluated, right ventricle free wall strain (RVFWS) and tricuspid regurgitant volume (RVol) were the strongest predictors of mortality in asymptomatic TR. The optimal discriminatory thresholds for these parameters were RVFWS <-19% and RVol >45 mL. The 5-year survival rates by number of risk factors (RF) were 93% (95% CI: 86%-96%), 65% (95% CI: 55%-74%), and 38% (95% CI: 26%-49%) for no RF, 1 RF, and both RFs, respectively. Compared with symptomatic TR, mortality was lower for asymptomatic TR with no RF (HR: 0.10; 95% CI: 0.04-0.29) or 1 RF (HR: 0.29; 95% CI: 0.14-0.58), but similar for asymptomatic TR with both RFs (HR: 1.11; 95% CI: 0.56-2.19).
CONCLUSIONS: RVFWS and RVol are key prognostic markers that can be serially monitored to inform optimal timing of intervention for severe asymptomatic TR.
引用
- Akintoye E, Wang TKM, Nakhla M, et al. Quantitative Echocardiographic Assessment and Optimal Criteria for Early Intervention in Asymptomatic Tricuspid Regurgitation. JACC Cardiovasc Imaging. 2022. PMID: 36274042. doi:10.1016/j.jcmg.2022.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。